Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 126

1.

Fructose, insulin resistance, and metabolic dyslipidemia.

Basciano H, Federico L, Adeli K.

Nutr Metab (Lond). 2005 Feb 21;2(1):5.PMID: 15723702 [PubMed - as supplied by publisher]Related articlesFree article

2.

High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation.

Rayssiguier Y, Gueux E, Nowacki W, Rock E, Mazur A.

Magnes Res. 2006 Dec;19(4):237-43. Review.PMID: 17402291 [PubMed - indexed for MEDLINE]Related articles

3.

Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion.

Avramoglu RK, Qiu W, Adeli K.

Front Biosci. 2003 Jan 1;8:d464-76. Review.PMID: 12456312 [PubMed - indexed for MEDLINE]Related articles

5.

Lipid and lipoprotein dysregulation in insulin resistant states.

Avramoglu RK, Basciano H, Adeli K.

Clin Chim Acta. 2006 Jun;368(1-2):1-19. Epub 2006 Feb 9. Review.PMID: 16480697 [PubMed - indexed for MEDLINE]Related articles

6.

Metabolic effects of fructose.

Lê KA, Tappy L.

Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):469-75. Review.PMID: 16778579 [PubMed - indexed for MEDLINE]Related articles

8.

Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance.

Adeli K, Taghibiglou C, Van Iderstine SC, Lewis GF.

Trends Cardiovasc Med. 2001 Jul;11(5):170-6. Review.PMID: 11597827 [PubMed - indexed for MEDLINE]Related articles

9.

Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity.

Bray GA, Nielsen SJ, Popkin BM.

Am J Clin Nutr. 2004 Apr;79(4):537-43. Review. Erratum in: Am J Clin Nutr. 2004 Oct;80(4):1090. PMID: 15051594 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance.

Stanhope KL, Havel PJ.

Curr Opin Lipidol. 2008 Feb;19(1):16-24. Review.PMID: 18196982 [PubMed - indexed for MEDLINE]Related articles

11.

Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia.

Kohen-Avramoglu R, Theriault A, Adeli K.

Clin Biochem. 2003 Sep;36(6):413-20. Review.PMID: 12951167 [PubMed - indexed for MEDLINE]Related articles

12.

Fructose, weight gain, and the insulin resistance syndrome.

Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ.

Am J Clin Nutr. 2002 Nov;76(5):911-22. Review.PMID: 12399260 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

Straight talk about high-fructose corn syrup: what it is and what it ain't.

White JS.

Am J Clin Nutr. 2008 Dec;88(6):1716S-1721S. Review.PMID: 19064536 [PubMed - indexed for MEDLINE]Related articles

14.

Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.

Reaven GM.

Panminerva Med. 2005 Dec;47(4):201-10. Review.PMID: 16489319 [PubMed - indexed for MEDLINE]Related articles

15.

Dietary fructose and glucose differentially affect lipid and glucose homeostasis.

Schaefer EJ, Gleason JA, Dansinger ML.

J Nutr. 2009 Jun;139(6):1257S-1262S. Epub 2009 Apr 29. Review.PMID: 19403705 [PubMed - indexed for MEDLINE]Related articles

16.

Dietary fructose and the metabolic syndrome.

Miller A, Adeli K.

Curr Opin Gastroenterol. 2008 Mar;24(2):204-9. Review.PMID: 18301272 [PubMed - indexed for MEDLINE]Related articles

17.

Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity.

Hsieh J, Hayashi AA, Webb J, Adeli K.

Atheroscler Suppl. 2008 Sep;9(2):7-13. Epub 2008 Jul 23. Review.PMID: 18653387 [PubMed - indexed for MEDLINE]Related articles

18.

Is fructose the optimal low glycemic index sweetener?

Bantle JP.

Nestle Nutr Workshop Ser Clin Perform Programme. 2006;11:83-91; discussion 92-5. Review.PMID: 16820733 [PubMed - indexed for MEDLINE]Related articles

19.

Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia.

Chong T, Naples M, Federico L, Taylor D, Smith GJ, Cheung RC, Adeli K.

Atherosclerosis. 2006 Mar;185(1):21-31. Epub 2005 Jul 5.PMID: 16002078 [PubMed - indexed for MEDLINE]Related articles

20.

Targeting the liver in the metabolic syndrome: evidence from animal models.

Petruzzelli M, Lo Sasso G, Portincasa P, Palasciano G, Moschetta A.

Curr Pharm Des. 2007;13(21):2199-207. Review.PMID: 17627553 [PubMed - indexed for MEDLINE]Related articles

Supplemental Content

Find related data

Recent activity